<meta http-equiv="Content-Type" content="text/html; charset=utf-8"><link type="text/css" rel="stylesheet" href="resources/sheet.css" >
<style type="text/css">.ritz .waffle a { color: inherit; }.ritz .waffle .s7{border-right: none;background-color:#ffffff;text-align:left;font-weight:bold;text-decoration:underline;-webkit-text-decoration-skip:none;text-decoration-skip-ink:none;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s0{background-color:#ffffff;text-align:left;font-weight:bold;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s5{border-left: none;border-right: none;background-color:#ffffff;text-align:left;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s9{background-color:#ffffff;text-align:left;color:#000000;font-family:'docs-Roboto',Arial;font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s6{border-right: none;background-color:#ffffff;text-align:left;text-decoration:underline;-webkit-text-decoration-skip:none;text-decoration-skip-ink:none;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s4{border-left: none;background-color:#ffffff;text-align:left;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s8{background-color:#ffffff;text-align:left;text-decoration:underline;-webkit-text-decoration-skip:none;text-decoration-skip-ink:none;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s1{background-color:#ffffff;text-align:left;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s2{border-right: none;background-color:#ffffff;text-align:left;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s3{border-right: none;background-color:#ffffff;text-align:left;font-weight:bold;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}</style><div class="ritz grid-container" dir="ltr"><table class="waffle" cellspacing="0" cellpadding="0"><thead><tr><th class="row-header freezebar-origin-ltr"></th><th id="139382858C0" style="width:136px;" class="column-headers-background">A</th><th id="139382858C1" style="width:100px;" class="column-headers-background">B</th></tr></thead><tbody><tr style="height: 17px"><th id="139382858R0" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">1</div></th><td class="s0" dir="ltr">HSV in Pregnancy</td><td class="s1"></td></tr><tr style="height: 17px"><th id="139382858R1" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">2</div></th><td class="s0" dir="ltr"></td><td class="s1"></td></tr><tr style="height: 17px"><th id="139382858R2" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">3</div></th><td class="s0" dir="ltr">Advice:</td><td class="s2 softmerge"><div class="softmerge-inner" style="width:2898px;left:-1px">Two types of HSV: Type 1 and 2. Type 2 accounts for 70% of genital herpes infections. HSV infection may be transmitted to neonates. Transmission is typically due to the neonate coming into contact with infected maternal secretions during delivery (transplacental infection reported but very rare). Highest risk with primary herpes infection within 6 weeks of delivery. Viral shedding can continue after lesions have healed.. Neonatal herpes is rare (UK incidence 3/100,000 live births) but serious. </div></td></tr><tr style="height: 17px"><th id="139382858R3" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">4</div></th><td class="s0" dir="ltr"></td><td class="s1"></td></tr><tr style="height: 17px"><th id="139382858R4" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">5</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:234px;left:-1px">Compiled situational advice:</div></td><td class="s4"></td></tr><tr style="height: 17px"><th id="139382858R5" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">6</div></th><td class="s1 softmerge"><div class="softmerge-inner" style="width:133px;left:-1px">HSV in Pregnancy - 1st or 2nd trimster acquisition</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:2941px;left:-1px">HSV in Pregnancy - 1st or 2nd trimster acquisition<br>Advice:	Two types of HSV: Type 1 and 2. Type 2 accounts for 70% of genital herpes infections. HSV infection may be transmitted to neonates. Transmission is typically due to the neonate coming into contact with infected maternal secretions during delivery (transplacental infection reported but very rare). Highest risk with primary herpes infection within 6 weeks of delivery. Viral shedding can continue after lesions have healed.. Neonatal herpes is rare (UK incidence 3/100,000 live births) but serious. <br>Refer to GUM for confirmation / screening / management plan<br>Initial episode treated acicolvir 400 mg TDS for 5 days - decreases duration / severity and viral shedding<br>Symptomatic therapy - paracetamol and topical lidocaine 2%<br>Following 1st or 2nd trimester acquisition, daily suppressive aciclovir 400 mg TDS from 36 weeks of gestation reduces HSV lesions at term and hence the need for delivery by caesarean section<br>If acquisition is 6 weeks from delivery, advise C-section to reduce neonatal HSV infection<br>RCOG BASH	Management Genital Herpes in pregnancy<br>Leaflet	https://www.rcog.org.uk/en/patients/patient-leaflets/genital-herpes-in-pregnancy/</div></td></tr><tr style="height: 17px"><th id="139382858R6" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">7</div></th><td class="s1 softmerge"><div class="softmerge-inner" style="width:133px;left:-1px">HSV in Pregnancy - 3rd trimester acquisition</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:2941px;left:-1px">HSV in Pregnancy - 3rd trimester acquisition<br>Advice:	Two types of HSV: Type 1 and 2. Type 2 accounts for 70% of genital herpes infections. HSV infection may be transmitted to neonates. Transmission is typically due to the neonate coming into contact with infected maternal secretions during delivery (transplacental infection reported but very rare). Highest risk with primary herpes infection within 6 weeks of delivery. Viral shedding can continue after lesions have healed.. Neonatal herpes is rare (UK incidence 3/100,000 live births) but serious. <br>41% chance of vertical transmission with vaginal delivery<br>Type-specific antibodies (IgG to HSV-1 and HSV-2) can distinguish between primary and recurrent infection, though can take up to 3 weeks for result<br>Assume all first-episode lesions to be primary rather than recurrent and plan for ELCS.<br>Discuss result with virologist / GUM physician to determine if outcome affects mode of delivery<br>Initiate acicolvir 400 mg TDS and continue until delivery<br>C-section delivery is advised for these patients in whom this is a 1st episode of HSV<br>RCOG BASH	Management Genital Herpes in pregnancy<br>Leaflet	https://www.rcog.org.uk/en/patients/patient-leaflets/genital-herpes-in-pregnancy/</div></td></tr><tr style="height: 17px"><th id="139382858R7" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">8</div></th><td class="s1 softmerge"><div class="softmerge-inner" style="width:133px;left:-1px">HSV in Pregnancy - Recurrent HSV infection</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:2941px;left:-1px">HSV in Pregnancy - Recurrent HSV infection<br>Advice:	Two types of HSV: Type 1 and 2. Type 2 accounts for 70% of genital herpes infections. HSV infection may be transmitted to neonates. Transmission is typically due to the neonate coming into contact with infected maternal secretions during delivery (transplacental infection reported but very rare). Highest risk with primary herpes infection within 6 weeks of delivery. Viral shedding can continue after lesions have healed.. Neonatal herpes is rare (UK incidence 3/100,000 live births) but serious. <br>Advise presence of lesions at delivery confers 0-3% risk of neonatal infeciton<br>Advise not indication for C-section<br>Saline baths and paracetamol should suffice<br>Offer daily suppressive therapy from 36 weeks (aciclovir 500mg TDS), reduces viral shedding and lesions at delivery, safety is not established therefore thorough counselling<br>RCOG BASH	Management Genital Herpes in pregnancy<br>Leaflet	https://www.rcog.org.uk/en/patients/patient-leaflets/genital-herpes-in-pregnancy/</div></td></tr><tr style="height: 17px"><th id="139382858R8" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">9</div></th><td class="s1 softmerge"><div class="softmerge-inner" style="width:133px;left:-1px">HSV in Pregnancy - Suspected primary HSV infection at the onset of labour</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:2941px;left:-1px">HSV in Pregnancy - Suspected primary HSV infection at the onset of labour<br>Advice:	Two types of HSV: Type 1 and 2. Type 2 accounts for 70% of genital herpes infections. HSV infection may be transmitted to neonates. Transmission is typically due to the neonate coming into contact with infected maternal secretions during delivery (transplacental infection reported but very rare). Highest risk with primary herpes infection within 6 weeks of delivery. Viral shedding can continue after lesions have healed.. Neonatal herpes is rare (UK incidence 3/100,000 live births) but serious. <br>Viral swab (as it may inform neonatal mx) and inform paeds/neonates<br>Advise C-section if history suggestive of primary HSV within 6 weeks (though possibly less effective if ROM &gt; 4 hours)<br>If vaginal delivery - IV aciclovir to mum and then neonate, avoid FBS/FSE/ARM/OVD<br>RCOG BASH	Management Genital Herpes in pregnancy<br>Leaflet	https://www.rcog.org.uk/en/patients/patient-leaflets/genital-herpes-in-pregnancy/</div></td></tr><tr style="height: 17px"><th id="139382858R9" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">10</div></th><td class="s1 softmerge"><div class="softmerge-inner" style="width:133px;left:-1px">HSV in Pregnancy - Suspected recurrent HSV infection at the onset of labour</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:2941px;left:-1px">HSV in Pregnancy - Suspected recurrent HSV infection at the onset of labour<br>Advice:	Two types of HSV: Type 1 and 2. Type 2 accounts for 70% of genital herpes infections. HSV infection may be transmitted to neonates. Transmission is typically due to the neonate coming into contact with infected maternal secretions during delivery (transplacental infection reported but very rare). Highest risk with primary herpes infection within 6 weeks of delivery. Viral shedding can continue after lesions have healed.. Neonatal herpes is rare (UK incidence 3/100,000 live births) but serious. <br>Advise 0%-3% risk of vertical transmission<br>Offer both vaginal and C-section<br>FBS/FSE/ARM/OVD can be used if required as small chance vertical transmission<br>No evidence IOL for PROM is protective but practice is commonplace<br>RCOG BASH	Management Genital Herpes in pregnancy<br>Leaflet	https://www.rcog.org.uk/en/patients/patient-leaflets/genital-herpes-in-pregnancy/</div></td></tr><tr style="height: 17px"><th id="139382858R10" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">11</div></th><td class="s1 softmerge"><div class="softmerge-inner" style="width:133px;left:-1px">HSV in Pregnancy - Primary genital herpes in preterm prelabour rupture of membranes (PPROM)</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:2941px;left:-1px">HSV in Pregnancy - Primary genital herpes in preterm prelabour rupture of membranes (PPROM)<br>Advice:	Two types of HSV: Type 1 and 2. Type 2 accounts for 70% of genital herpes infections. HSV infection may be transmitted to neonates. Transmission is typically due to the neonate coming into contact with infected maternal secretions during delivery (transplacental infection reported but very rare). Highest risk with primary herpes infection within 6 weeks of delivery. Viral shedding can continue after lesions have healed.. Neonatal herpes is rare (UK incidence 3/100,000 live births) but serious. <br>Limited evidence in this particular situation<br>Confer with MDT (obs / neonates / GUM) with gestation being the over-riding factor<br>If delivery indicated, advise C-section.<br>If conservative mx mother should be recommended to receive intravenous aciclovir 5 mg/kg every 8 hours<br>Consider prophylactic corticosteroids reduce the implications of preterm delivery upon the infant.<br>If delivery is indicated within 6 weeks of the primary infection, delivery by caesarean section may still offer some benefit despite the prolonged rupture of membranes.<br>RCOG BASH	Management Genital Herpes in pregnancy<br>Leaflet	https://www.rcog.org.uk/en/patients/patient-leaflets/genital-herpes-in-pregnancy/</div></td></tr><tr style="height: 17px"><th id="139382858R11" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">12</div></th><td class="s1 softmerge"><div class="softmerge-inner" style="width:133px;left:-1px">HSV in Pregnancy - Recurrent genital herpes in PPROM</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:2941px;left:-1px">HSV in Pregnancy - Recurrent genital herpes in PPROM<br>Advice:	Two types of HSV: Type 1 and 2. Type 2 accounts for 70% of genital herpes infections. HSV infection may be transmitted to neonates. Transmission is typically due to the neonate coming into contact with infected maternal secretions during delivery (transplacental infection reported but very rare). Highest risk with primary herpes infection within 6 weeks of delivery. Viral shedding can continue after lesions have healed.. Neonatal herpes is rare (UK incidence 3/100,000 live births) but serious. <br>Risk of neonatal transmission is very small and may be outweighed by the morbidity and mortality associated with premature delivery.<br>In the case of PPROM before 34 weeks there is evidence to suggest that expectant management is appropriate, including oral aciclovir 400 mg three times daily for the mother. <br>After 34 weeks gestation, it is recommended that management is undertaken in accordance with relevant RCOG guidelines on PPROM and antenatal corticosteroid administration to reduce neonatal morbidity and mortality and is not materially influenced by the presence of recurrent genital herpes lesions.<br>RCOG BASH	Management Genital Herpes in pregnancy<br>Leaflet	https://www.rcog.org.uk/en/patients/patient-leaflets/genital-herpes-in-pregnancy/</div></td></tr><tr style="height: 17px"><th id="139382858R12" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">13</div></th><td class="s0" dir="ltr"></td><td class="s1"></td></tr><tr style="height: 17px"><th id="139382858R13" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">14</div></th><td class="s0" dir="ltr"></td><td class="s1"></td></tr><tr style="height: 17px"><th id="139382858R14" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">15</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:334px;left:-1px">Herpes Simplex (HSV) in Pregnancy Key Points</div></td><td class="s5"></td></tr><tr style="height: 17px"><th id="139382858R15" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">16</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">Two types of HSV: Type 1 and 2. Type 2 accounts for 70% of genital herpes infections</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:598px;left:-1px">Two types of HSV: Type 1 and 2. Type 2 accounts for 70% of genital herpes infections. </div></td></tr><tr style="height: 17px"><th id="139382858R16" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">17</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">HSV infection may be transmitted to neonates. Transmission is typically due to the neonate coming into contact with infected maternal secretions during delivery (transplacental infection reported but very rare)</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:1298px;left:-1px">HSV infection may be transmitted to neonates. Transmission is typically due to the neonate coming into contact with infected maternal secretions during delivery (transplacental infection reported but very rare). </div></td></tr><tr style="height: 17px"><th id="139382858R17" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">18</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">Highest risk with primary herpes infection within 6 weeks of delivery. Viral shedding can continue after lesions have healed.</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:798px;left:-1px">Highest risk with primary herpes infection within 6 weeks of delivery. Viral shedding can continue after lesions have healed.. </div></td></tr><tr style="height: 17px"><th id="139382858R18" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">19</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">Neonatal herpes is rare (UK incidence 3/100,000 live births) but serious</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:498px;left:-1px">Neonatal herpes is rare (UK incidence 3/100,000 live births) but serious. </div></td></tr><tr style="height: 17px"><th id="139382858R19" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">20</div></th><td class="s1"></td><td class="s1"></td></tr><tr style="height: 17px"><th id="139382858R20" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">21</div></th><td class="s6 softmerge" dir="ltr"><div class="softmerge-inner" style="width:234px;left:-1px">3 types of Neonatal herpes:</div></td><td class="s4"></td></tr><tr style="height: 17px"><th id="139382858R21" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">22</div></th><td class="s2 softmerge" dir="ltr"><div class="softmerge-inner" style="width:534px;left:-1px">1. Restricted to skin/superfical infection (eye/mouth) which is the least severe form</div></td><td class="s5"></td></tr><tr style="height: 17px"><th id="139382858R22" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">23</div></th><td class="s2 softmerge" dir="ltr"><div class="softmerge-inner" style="width:534px;left:-1px">2. CNS infection (mortality with antiviral treatment 6% neurological sequelae 70%)</div></td><td class="s5"></td></tr><tr style="height: 17px"><th id="139382858R23" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">24</div></th><td class="s2 softmerge" dir="ltr"><div class="softmerge-inner" style="width:634px;left:-1px">3. Disseminated infection (mortality with antiviral treatment 30% neurological sequelae 17%)</div></td><td class="s5"></td></tr><tr style="height: 17px"><th id="139382858R24" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">25</div></th><td class="s2 softmerge" dir="ltr"><div class="softmerge-inner" style="width:334px;left:-1px">70% of cases are disseminated or CNS involvement</div></td><td class="s5"></td></tr><tr style="height: 17px"><th id="139382858R25" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">26</div></th><td class="s1" dir="ltr"></td><td class="s1"></td></tr><tr style="height: 17px"><th id="139382858R26" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">27</div></th><td class="s7 softmerge" dir="ltr"><div class="softmerge-inner" style="width:234px;left:-1px"><a target="_blank" href="https://www.rcog.org.uk/globalassets/documents/guidelines/management-genital-herpes.pdf">1st or 2nd trimster acquisition</a></div></td><td class="s4"></td></tr><tr style="height: 17px"><th id="139382858R27" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">28</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">Refer to GUM for confirmation / screening / management plan</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:398px;left:-1px">Refer to GUM for confirmation / screening / management plan<br></div></td></tr><tr style="height: 17px"><th id="139382858R28" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">29</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">Initial episode treated acicolvir 400 mg TDS for 5 days - decreases duration / severity and viral shedding</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:698px;left:-1px">Initial episode treated acicolvir 400 mg TDS for 5 days - decreases duration / severity and viral shedding<br></div></td></tr><tr style="height: 17px"><th id="139382858R29" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">30</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">Symptomatic therapy - paracetamol and topical lidocaine 2%</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:398px;left:-1px">Symptomatic therapy - paracetamol and topical lidocaine 2%<br></div></td></tr><tr style="height: 17px"><th id="139382858R30" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">31</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">Following 1st or 2nd trimester acquisition, daily suppressive aciclovir 400 mg TDS from 36 weeks of gestation reduces HSV lesions at term and hence the need for delivery by caesarean section</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:1198px;left:-1px">Following 1st or 2nd trimester acquisition, daily suppressive aciclovir 400 mg TDS from 36 weeks of gestation reduces HSV lesions at term and hence the need for delivery by caesarean section<br></div></td></tr><tr style="height: 17px"><th id="139382858R31" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">32</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">If acquisition is 6 weeks from delivery, advise C-section to reduce neonatal HSV infection</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:598px;left:-1px">If acquisition is 6 weeks from delivery, advise C-section to reduce neonatal HSV infection<br></div></td></tr><tr style="height: 17px"><th id="139382858R32" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">33</div></th><td class="s1"></td><td class="s1"></td></tr><tr style="height: 17px"><th id="139382858R33" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">34</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:234px;left:-1px">3rd trimester acquisition</div></td><td class="s4"></td></tr><tr style="height: 17px"><th id="139382858R34" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">35</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">41% chance of vertical transmission with vaginal delivery</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:398px;left:-1px">41% chance of vertical transmission with vaginal delivery<br></div></td></tr><tr style="height: 17px"><th id="139382858R35" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">36</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">Type-specific antibodies (IgG to HSV-1 and HSV-2) can distinguish between primary and recurrent infection, though can take up to 3 weeks for result</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:898px;left:-1px">Type-specific antibodies (IgG to HSV-1 and HSV-2) can distinguish between primary and recurrent infection, though can take up to 3 weeks for result<br></div></td></tr><tr style="height: 17px"><th id="139382858R36" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">37</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">Assume all first-episode lesions to be primary rather than recurrent and plan for ELCS.</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:598px;left:-1px">Assume all first-episode lesions to be primary rather than recurrent and plan for ELCS.<br></div></td></tr><tr style="height: 17px"><th id="139382858R37" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">38</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">Discuss result with virologist / GUM physician to determine if outcome affects mode of delivery</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:598px;left:-1px">Discuss result with virologist / GUM physician to determine if outcome affects mode of delivery<br></div></td></tr><tr style="height: 17px"><th id="139382858R38" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">39</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">Initiate acicolvir 400 mg TDS and continue until delivery</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:398px;left:-1px">Initiate acicolvir 400 mg TDS and continue until delivery<br></div></td></tr><tr style="height: 17px"><th id="139382858R39" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">40</div></th><td class="s8 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">C-section delivery is advised for these patients in whom this is a 1st episode of HSV</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:498px;left:-1px">C-section delivery is advised for these patients in whom this is a 1st episode of HSV<br></div></td></tr><tr style="height: 17px"><th id="139382858R40" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">41</div></th><td class="s1"></td><td class="s1"></td></tr><tr style="height: 17px"><th id="139382858R41" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">42</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:234px;left:-1px">Recurrent HSV infection</div></td><td class="s4"></td></tr><tr style="height: 17px"><th id="139382858R42" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">43</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">Advise presence of lesions at delivery confers 0-3% risk of neonatal infeciton</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:498px;left:-1px">Advise presence of lesions at delivery confers 0-3% risk of neonatal infeciton<br></div></td></tr><tr style="height: 17px"><th id="139382858R43" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">44</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">Advise not indication for C-section</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:298px;left:-1px">Advise not indication for C-section<br></div></td></tr><tr style="height: 17px"><th id="139382858R44" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">45</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">Saline baths and paracetamol should suffice</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:298px;left:-1px">Saline baths and paracetamol should suffice<br></div></td></tr><tr style="height: 17px"><th id="139382858R45" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">46</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">Offer daily suppressive therapy from 36 weeks (aciclovir 500mg TDS), reduces viral shedding and lesions at delivery, safety is not established therefore thorough counselling</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:1098px;left:-1px">Offer daily suppressive therapy from 36 weeks (aciclovir 500mg TDS), reduces viral shedding and lesions at delivery, safety is not established therefore thorough counselling<br></div></td></tr><tr style="height: 17px"><th id="139382858R46" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">47</div></th><td class="s1"></td><td class="s1"></td></tr><tr style="height: 17px"><th id="139382858R47" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">48</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:434px;left:-1px">Suspected primary HSV infection at the onset of labour</div></td><td class="s5"></td></tr><tr style="height: 17px"><th id="139382858R48" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">49</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">Viral swab (as it may inform neonatal mx) and inform paeds/neonates</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:498px;left:-1px">Viral swab (as it may inform neonatal mx) and inform paeds/neonates<br></div></td></tr><tr style="height: 17px"><th id="139382858R49" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">50</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">Advise C-section if history suggestive of primary HSV within 6 weeks (though possibly less effective if ROM &gt; 4 hours)</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:698px;left:-1px">Advise C-section if history suggestive of primary HSV within 6 weeks (though possibly less effective if ROM &gt; 4 hours)<br></div></td></tr><tr style="height: 17px"><th id="139382858R50" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">51</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">If vaginal delivery - IV aciclovir to mum and then neonate, avoid FBS/FSE/ARM/OVD</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:498px;left:-1px">If vaginal delivery - IV aciclovir to mum and then neonate, avoid FBS/FSE/ARM/OVD<br></div></td></tr><tr style="height: 17px"><th id="139382858R51" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">52</div></th><td class="s1"></td><td class="s1"></td></tr><tr style="height: 17px"><th id="139382858R52" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">53</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:434px;left:-1px">Suspected recurrent HSV infection at the onset of labour</div></td><td class="s5"></td></tr><tr style="height: 17px"><th id="139382858R53" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">54</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">Advise 0%-3% risk of vertical transmission</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:298px;left:-1px">Advise 0%-3% risk of vertical transmission<br></div></td></tr><tr style="height: 17px"><th id="139382858R54" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">55</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">Offer both vaginal and C-section</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:198px;left:-1px">Offer both vaginal and C-section<br></div></td></tr><tr style="height: 17px"><th id="139382858R55" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">56</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">FBS/FSE/ARM/OVD can be used if required as small chance vertical transmission</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:498px;left:-1px">FBS/FSE/ARM/OVD can be used if required as small chance vertical transmission<br></div></td></tr><tr style="height: 17px"><th id="139382858R56" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">57</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">No evidence IOL for PROM is protective but practice is commonplace</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:498px;left:-1px">No evidence IOL for PROM is protective but practice is commonplace<br></div></td></tr><tr style="height: 17px"><th id="139382858R57" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">58</div></th><td class="s1"></td><td class="s1"></td></tr><tr style="height: 17px"><th id="139382858R58" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">59</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:534px;left:-1px">Primary genital herpes in preterm prelabour rupture of membranes (PPROM)</div></td><td class="s5"></td></tr><tr style="height: 17px"><th id="139382858R59" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">60</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">Limited evidence in this particular situation</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:298px;left:-1px">Limited evidence in this particular situation<br></div></td></tr><tr style="height: 17px"><th id="139382858R60" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">61</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">Confer with MDT (obs / neonates / GUM) with gestation being the over-riding factor</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:498px;left:-1px">Confer with MDT (obs / neonates / GUM) with gestation being the over-riding factor<br></div></td></tr><tr style="height: 17px"><th id="139382858R61" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">62</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">If delivery indicated, advise C-section.</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:298px;left:-1px">If delivery indicated, advise C-section.<br></div></td></tr><tr style="height: 17px"><th id="139382858R62" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">63</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">If conservative mx mother should be recommended to receive intravenous aciclovir 5 mg/kg every 8 hours</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:698px;left:-1px">If conservative mx mother should be recommended to receive intravenous aciclovir 5 mg/kg every 8 hours<br></div></td></tr><tr style="height: 17px"><th id="139382858R63" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">64</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">Consider prophylactic corticosteroids reduce the implications of preterm delivery upon the infant.</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:598px;left:-1px">Consider prophylactic corticosteroids reduce the implications of preterm delivery upon the infant.<br></div></td></tr><tr style="height: 17px"><th id="139382858R64" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">65</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">If delivery is indicated within 6 weeks of the primary infection, delivery by caesarean section may still offer some benefit despite the prolonged rupture of membranes.</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:998px;left:-1px">If delivery is indicated within 6 weeks of the primary infection, delivery by caesarean section may still offer some benefit despite the prolonged rupture of membranes.<br></div></td></tr><tr style="height: 17px"><th id="139382858R65" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">66</div></th><td class="s1"></td><td class="s1"></td></tr><tr style="height: 17px"><th id="139382858R66" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">67</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:334px;left:-1px">Recurrent genital herpes in PPROM</div></td><td class="s5"></td></tr><tr style="height: 17px"><th id="139382858R67" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">68</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">Risk of neonatal transmission is very small and may be outweighed by the morbidity and mortality associated with premature delivery.</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:798px;left:-1px">Risk of neonatal transmission is very small and may be outweighed by the morbidity and mortality associated with premature delivery.<br></div></td></tr><tr style="height: 17px"><th id="139382858R68" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">69</div></th><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">In the case of PPROM before 34 weeks there is evidence to suggest that expectant management is appropriate, including oral aciclovir 400 mg three times daily for the mother. </div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:1098px;left:-1px">In the case of PPROM before 34 weeks there is evidence to suggest that expectant management is appropriate, including oral aciclovir 400 mg three times daily for the mother. <br></div></td></tr><tr style="height: 17px"><th id="139382858R69" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">70</div></th><td class="s9 softmerge" dir="ltr"><div class="softmerge-inner" style="width:133px;left:-1px">After 34 weeks gestation, it is recommended that management is undertaken in accordance with relevant RCOG guidelines on PPROM and antenatal corticosteroid administration to reduce neonatal morbidity and mortality and is not materially influenced by the presence of recurrent genital herpes lesions.</div></td><td class="s2 softmerge"><div class="softmerge-inner" style="width:1798px;left:-1px">After 34 weeks gestation, it is recommended that management is undertaken in accordance with relevant RCOG guidelines on PPROM and antenatal corticosteroid administration to reduce neonatal morbidity and mortality and is not materially influenced by the presence of recurrent genital herpes lesions.<br></div></td></tr><tr style="height: 17px"><th id="139382858R70" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">71</div></th><td></td><td></td></tr><tr style="height: 17px"><th id="139382858R71" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">72</div></th><td class="s1">RCOG BASH</td><td class="s6 softmerge"><div class="softmerge-inner" style="width:298px;left:-1px"><a target="_blank" href="https://www.rcog.org.uk/globalassets/documents/guidelines/management-genital-herpes.pdf">Management Genital Herpes in pregnancy</a></div></td></tr><tr style="height: 17px"><th id="139382858R72" style="height: 17px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 17px">73</div></th><td class="s1" dir="ltr">Leaflet</td><td class="s6 softmerge"><div class="softmerge-inner" style="width:498px;left:-1px"><a target="_blank" href="https://www.rcog.org.uk/en/patients/patient-leaflets/genital-herpes-in-pregnancy/">https://www.rcog.org.uk/en/patients/patient-leaflets/genital-herpes-in-pregnancy/</a></div></td></tr></tbody></table></div>